Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
36005 POSTS 0 COMMENTS
Refeeding patients with anorexia nervosa to achieve more rapid weight gain can be safe and effective in a hospital-based protocol

More Rapid Refeeding Protocol Seems Safe in Anorexia Nervosa

0
2 kg/week weight gain appears safe for patients; low hypophosphatemia rates seen
During 2002 to 2011

Productivity Growth in U.S. Hospitals During 2002 to 2011

0
In adjusted analyses, productivity growth seen for treatment of heart attack, heart failure, pneumonia
Usage of nondrug

Use of Nondrug, Nonsurgical Options Low in Hip, Knee OA

0
Docs need to encourage patients to use exercise, weight loss as recommended in guidelines
Some bakery products sold as free of cow's milk may not be safe for those with milk allergies because they still contain milk protein

Milk Protein Detected in Some ‘Cow’s Milk-Free’ Baked Goods

0
Cow's milk protein detected in non-prepacked bakery products sold as free of cow's milk
For individuals with dementia living in nursing homes

Antipsychotic Rx Often Relates to Non-Approved Indications

0
Major categories of reasons for medication use are behavioral, psychiatric, emotional states, cognition
Considerable practice variation exists among surgeons at a high-volume academic center when selecting patients with prostate cancer to undergo radical prostatectomy

Considerable Surgeon-Level Variation in Radical Prostatectomy

0
Variation exists at high-volume center when selecting patients with low-risk prostate cancer
Many adults maintain adequate serum 25-hydroxyvitamin D levels even in periods of minimal ultraviolet radiation exposure

Many Adults Maintain Adequate Vitamin D With Minimal UVR

0
Review shows adequate serum vitamin D levels despite negligible ultraviolet radiation exposure
For individuals with HIV and chronic pain

Various Strategies Used by Patients With HIV, Chronic Pain

0
Some, such as substance use, may have negative health consequences
For postmenopausal women

Lycopene Inversely Linked to Renal Cell Carcinoma Risk

0
Findings from 96,196 postmenopausal women enrolled in Women's Health Initiative
The kinase inhibitor Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

FDA Approves Lenvima for Type of Thyroid Cancer

0
To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy